SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 71.89M
December 31, 2025 91.29M
September 30, 2025 76.13M
June 30, 2025 73.40M
March 31, 2025 73.08M
December 31, 2024 54.43M
September 30, 2024 37.21M
June 30, 2024 30.43M
March 31, 2024 23.07M
December 31, 2023 23.30M
September 30, 2023 23.35M
June 30, 2023 13.46M
March 31, 2023 2.903M
December 31, 2022 2.507M
September 30, 2022 2.698M
June 30, 2022 2.569M
March 31, 2022 2.368M
Date Value
December 31, 2021 2.171M
September 30, 2021 1.174M
June 30, 2021 0.9841M
March 31, 2021 0.8577M
December 31, 2020 0.7063M
September 30, 2020 1.042M
June 30, 2020 1.203M
March 31, 2020 1.262M
June 30, 2019 1.461M
March 31, 2019 1.472M
December 31, 2018 1.467M
September 30, 2018 1.230M
June 30, 2018 0.9578M
March 31, 2018 0.6112M
December 31, 2017 0.2835M
September 30, 2017 0.1623M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
AMN Healthcare Services, Inc. 656.52M
Agilent Technologies, Inc. 1.844B
Bio-Rad Laboratories, Inc. 852.20M
Bruker Corp. 970.70M
Azenta, Inc. 257.38M